Dermatology NewsLebrikizumab gets European nod for treating moderate-to-severe atopic dermatitisNovember 17, 2023Atopic DermatitisPediatrics
Dermatology NewsIV secukinumab, alternative to self-injections, reaches primary endpoints in PsA, axSpANovember 17, 2023Psoriatic Arthritis
Dermatology NewsNew at-home test approved for chlamydia and gonorrheaNovember 17, 2023Infectious Diseases
Dupilumab for Dyshidrotic Eczema With Secondary Improvement in Eosinophilic Interstitial Lung DiseaseNovember 16, 2023Atopic Dermatitis
Paradoxical Reaction to TNF-α Inhibitor Therapy in a Patient With Hidradenitis SuppurativaNovember 16, 2023PsoriasisAutoimmune Diseases
Impact of the COVID-19 Pandemic on Care for Patients With Atopic DermatitisNovember 16, 2023Atopic DermatitisCOVID-19 Updates
Aberrant Expression of CD56 in Metastatic Malignant MelanomaNovember 16, 2023DermatopathologyMelanoma
Dermatology NewsFTC considers proposals on mergers and noncompete clausesNovember 16, 2023Business of MedicinePractice Management
Dermatology NewsLower-extremity lymphedema associated with more skin cancer riskNovember 15, 2023Nonmelanoma Skin CancerMelanoma
Dermatology NewsApremilast beats placebo in early PsA affecting few jointsNovember 14, 2023Psoriatic Arthritis
